logo

PROC(Delisted)

ProcapsยทNASDAQ
--
--(--)

PROC Profile

Procaps Group, S.A.

A leading developer and manufacturer of customized softgel capsules for the healthcare and nutraceutical industries

--
12/06/2018
12/09/2019
NASDAQ Stock Exchange
5,564
12-31
Common stock
9 rue de Bitbourg, L-1273, Luxembourg, Grand Duchy of Luxembourg, R.C.S. Luxembourg: B253360
--
Procaps Group, S.A. was incorporated on December 6, 2018. The ProCaps Group is a developer of pharmaceutical and nutritional health solutions, pharmaceuticals and hospital supplies in more than 50 countries on five continents. ProCaps has direct operations in 13 countries in Latin America. ProCaps develops, manufactures and sells over-the-counter and prescription drugs, nutritional supplements and high-efficiency clinical solutions.